Xiaomin Li, Jiefeng He, Xiaojing Ren, Haichao Zhao, & Haoliang Zhao. (2020). Circ_0003998 enhances doxorubicin resistance in hepatocellular carcinoma by regulating miR-218-5p/EIF5A2 pathway. BMC.
Chicago Style (17th ed.) CitationXiaomin Li, Jiefeng He, Xiaojing Ren, Haichao Zhao, and Haoliang Zhao. Circ_0003998 Enhances Doxorubicin Resistance in Hepatocellular Carcinoma by Regulating MiR-218-5p/EIF5A2 Pathway. BMC, 2020.
MLA (9th ed.) CitationXiaomin Li, et al. Circ_0003998 Enhances Doxorubicin Resistance in Hepatocellular Carcinoma by Regulating MiR-218-5p/EIF5A2 Pathway. BMC, 2020.
Warning: These citations may not always be 100% accurate.